The first strategy, exenatide was the first GLP-1 analog introduced for the treatment of patients with type 2 diabetes
Weve barely scratched the surface
These tests include measurements of estimated glomerular filtration rate (eGFR) , urinary albumin-to-creatinine ratio (UACR) , blood glucose levels , HbA1c , blood pressure , weight , lipid panel , electrolytes , and markers of bone health such as calcium , phosphate , and parathyroid hormone (PTH)
No Compromise
Think of this classification as a yellow warning light rather than a red stop signits not proven dangerous, but its not proven safe either
There is such a shortage of these drugs worldwide that doctors have been asked to stop writing new prescriptions until suppliers can produce more